Display options
Share it on

Clin Med Insights Womens Health. 2014 Jun 16;7:17-24. doi: 10.4137/CMWH.S13955. eCollection 2014.

Weight Loss Intervention in Survivors of ER/PR-negative Breast Cancer.

Clinical medicine insights. Women's health

Mara Z Vitolins, Brandy-Joe Milliron, Judith O Hopkins, Artie Fulmer, Julia Lawrence, Susan Melin, Douglas Case

Affiliations

  1. Division of Public Health Sciences, Wake Forest University Health Sciences, Medical Center Blvd, Winston-Salem, NC, USA. ; Wake Forest University Comprehensive Cancer Center, Wake Forest University Health Sciences, Winston-Salem, NC, USA.
  2. Department of Nutrition Sciences, College of Nursing and Health Professions, Drexel University, Philadelphia, PA USA.
  3. Derrick L. Davis Forsyth Regional Cancer Center, Winston-Salem, NC, USA.
  4. Division of Public Health Sciences, Wake Forest University Health Sciences, Medical Center Blvd, Winston-Salem, NC, USA.
  5. Wake Forest University Comprehensive Cancer Center, Wake Forest University Health Sciences, Winston-Salem, NC, USA.

PMID: 24987274 PMCID: PMC4069035 DOI: 10.4137/CMWH.S13955

Abstract

Numerous studies have found that increased body size (weight or body mass index) is a risk factor for breast cancer development, recurrence, and death. The detrimental relationship between body size and breast cancer recurrence may be more pronounced among women with estrogen receptor (ER)/progesterone receptor (PR)-negative breast cancer. Considering the limited availability of treatments, and the association between body size and recurrence, alternative treatments are needed for ER/PR-negative breast cancer survivors, particularly overweight survivors. The objective of this pilot study was to examine the feasibility of a 12-week, multi-component meal-replacement weight loss intervention among overweight or obese ER/PR-negative breast cancer survivors; and to obtain preliminary data on changes in anthropometrics, biomarkers, and health-related quality of life (QOL). The 12-week intervention included a portion-controlled diet (including meal replacements) and a multi-component intervention (including behavioral techniques, diet modification, physical activity, and social support). The goal of the intervention was to help participants lose 5% or more of their initial weight by reducing their caloric intake and increasing their physical activity (to at least 15 minutes each day). Paired t-tests assessed changes in continuous measures. Body weight was measured weekly and mixed-model regression analysis assessed change in weight over time. Nineteen ER/PR-negative breast cancer survivors with a mean age of 59 years participated in the study. All but two of the participants completed the 12-week intervention. Women lost an average of 6.3 ± 4.9 kg (P < 0.001), equivalent to 7.5% of their baseline weight. There were significant reductions in waist circumference (P = 0.001), percent fat mass (P < 0.001), total cholesterol (P = 0.026), and triglycerides (P = 0.002); and improvements in health-related QOL (P = 0.017). Findings suggested that a meal-replacement weight loss approach among ER/PR-negative breast cancer survivors was feasible and was well received.

Keywords: estrogen negative breast cancer; meal replacement; nutrition intervention; weight loss

References

  1. Nutr J. 2008 Aug 27;7:23 - PubMed
  2. CA Cancer J Clin. 2012 Jul-Aug;62(4):243-74 - PubMed
  3. Curr Nutr Food Sci. 2012 Nov;8(4):320-329 - PubMed
  4. Endocr Relat Cancer. 2011 Jul 04;18(4):R125-47 - PubMed
  5. Metabolism. 2007 Feb;56(2):280-8 - PubMed
  6. Growth Horm IGF Res. 2004 Oct;14(5):337-75 - PubMed
  7. J Am Diet Assoc. 2001 Mar;101(3):345-7 - PubMed
  8. Nat Rev Cancer. 2004 Jul;4(7):505-18 - PubMed
  9. Breast J. 2008 Jul-Aug;14(4):357-65 - PubMed
  10. Nutr Metab (Lond). 2011 Sep 22;8(1):64 - PubMed
  11. Eur J Clin Nutr. 2003 Apr;57(4):514-22 - PubMed
  12. Nutr J. 2003 Nov 18;2:14 - PubMed
  13. Breast Cancer Res Treat. 2010 Oct;123(3):627-35 - PubMed
  14. Am J Clin Nutr. 2012 Jul;96(1):123-32 - PubMed
  15. J Am Diet Assoc. 2010 Jun;110(6):879-91 - PubMed
  16. JAMA. 1991 Sep 18;266(11):1535-42 - PubMed
  17. Ethn Health. 1996 Dec;1(4):337-47 - PubMed
  18. Eur J Clin Nutr. 2005 Mar;59(3):411-8 - PubMed
  19. J Clin Oncol. 2002 Feb 15;20(4):1128-43 - PubMed
  20. Food Chem. 2014;152:423-31 - PubMed
  21. Int J Obes Relat Metab Disord. 2003 May;27(5):537-49 - PubMed
  22. J Nutr. 2004 Aug;134(8):1894-9 - PubMed
  23. Obes Surg. 2014 Sep;24(9):1476-80 - PubMed
  24. Am J Clin Nutr. 2005 Jul;82(1 Suppl):230S-235S - PubMed
  25. Menopause. 2003 Jul-Aug;10(4):322-31 - PubMed
  26. J Consult Clin Psychol. 1997 Apr;65(2):278-85 - PubMed
  27. J Clin Oncol. 1993 Mar;11(3):570-9 - PubMed
  28. Ann Nutr Metab. 2008;52(1):74-8 - PubMed
  29. Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):270-4 - PubMed
  30. J Am Coll Nutr. 2005 Jun;24(3):210-6 - PubMed
  31. Nutr J. 2010 Dec 31;9:72 - PubMed
  32. Eat Behav. 2009 Aug;10(3):176-83 - PubMed
  33. J Clin Oncol. 2002 Jan 1;20(1):42-51 - PubMed
  34. Eur J Clin Nutr. 2009 Oct;63(10):1226-32 - PubMed
  35. Clin Med Res. 2009 Jun;7(1-2):4-13 - PubMed
  36. Breast Cancer Res. 2007;9(1):R6 - PubMed

Publication Types

Grant support